Products and services

1. Production of effective biomedical cell products (BMCP) based on dendritic cells.:
– monocytic dendritic cells primed with synthetic peptides;
– monocytic dendritic cells primed with a tumor lysate;
– monocytic dendritic cells primed with synthetic peptides and tumor lysate;

2. Methods of cancer immunotherapy using BMCP based on  monocytic dendritic cells primed with a tumor lysate and/or synthetic peptides for the treatment and medical prevention of relapse in patients with cancer;

3. Depositing cell cultures into a biotechnological collection of human and animal cell cultures;

4. Development of technologies for creating liposomal forms of medicinal and veterinary drugs;

5. Implementation of the development of ozone technologies for asepticizing water, fruits, and vegetables, grain, storage facilities, and equipment;

6. Performing research work on computer-aided structurally-based drug development, software development for computer-aided drug design, and virtual screening.